Viktor Y. Umansky

Mannheim, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 167 publications

Expert opinion on burning questions in cancer myeloid cell biology.

Expert opinion on burning questions in cancer myeloid cell biology.

Journal: Journal for immunotherapy of cancer

Published: May 04, 2026

Monocytes acquire a tumor-associated IL1B program upon encountering patient-derived colon cancer organoids.

Monocytes acquire a tumor-associated IL1B program upon encountering patient-derived colon cancer organoids.

Journal: Oncoimmunology

Published: February 22, 2026

In vitro generation of human CD14+ MDSC-like cells from normal human monocytes.

In vitro generation of human CD14+ MDSC-like cells from normal human monocytes.

Journal: Methods in cell biology

Published: January 31, 2026

Neural crest-associated gene FOXD1 induces an immunosuppressive microenvironment by regulating myeloid-derived suppressor cells in melanoma.

Neural crest-associated gene FOXD1 induces an immunosuppressive microenvironment by regulating myeloid-derived suppressor cells in melanoma.

Journal: Journal for immunotherapy of cancer

Published: March 26, 2025

Generation and functional analysis of melanoma antigen-specific CD8+ T cells derived from S/MAR vector-transfected human induced pluripotent stem cells.

Generation and functional analysis of melanoma antigen-specific CD8+ T cells derived from S/MAR vector-transfected human induced pluripotent stem cells.

Journal: International journal of cancer

Published: September 03, 2024

The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy.

The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy.

Journal: Molecular oncology

Published: August 13, 2024

S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling.

S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling.

Journal: Journal for immunotherapy of cancer

Published: August 01, 2024

Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion.

Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion.

Journal: Cell death & disease

Published: July 10, 2024

Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in Melanoma.

Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in Melanoma.

Journal: International journal of molecular sciences

Published: March 28, 2024

Myeloid-derived suppressor cells in peripheral blood as predictive biomarkers in patients with solid tumors undergoing immune checkpoint therapy: systematic review and meta-analysis.

Myeloid-derived suppressor cells in peripheral blood as predictive biomarkers in patients with solid tumors undergoing immune checkpoint therapy: systematic review and meta-analysis.

Journal: Frontiers in immunology

Published: March 19, 2024

Myeloid-derived suppressor cells in cancer and cancer therapy.

Myeloid-derived suppressor cells in cancer and cancer therapy.

Journal: Nature reviews. Clinical oncology

Published: November 29, 2023

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs.

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs.

Journal: Oncoimmunology

Published: August 18, 2023

Showing 1-12 of 167

Last Updated: 09/26/2026